{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:03:50Z","timestamp":1771999430798,"version":"3.50.1"},"reference-count":5,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"DOI":"10.25259\/ijdvl_549_2021","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T11:41:20Z","timestamp":1658922080000},"page":"845-848","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Switching immune sensitizer agents in refractory alopecia areata as a valuable therapeutic strategy a retrospective case series"],"prefix":"10.25259","volume":"88","author":[{"given":"Maira Elizabeth","family":"Herz-Ruelas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Ocampo-Candiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minerva","family":"G\u00f3mez-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Carolina","family":"Mart\u00ednez-Rico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Ch\u00e1vez-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca Carolina","family":"Rivera-Izaguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"10.25259\/IJDVL_549_2021\/ref-1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","article-title":"Alopecia areata: An appraisal of new treatment approaches and overview of current therapies","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_549_2021\/ref-2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.23736\/S0392-0488.19.06458-7","article-title":"Italian Guidelines in diagnosis and treatment of alopecia areata","volume":"154","author":"Rossi","year":"2019","journal-title":"G Ital Dermatol Venereol"},{"key":"10.25259\/IJDVL_549_2021\/ref-3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines-Part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.25259\/IJDVL_549_2021\/ref-4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/jamadermatol.2018.2312","article-title":"Hair regrowth outcomes of contact immunotherapy for patients with Alopecia Areata: A Systematic review and meta-analysis","volume":"154","author":"Lee","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.25259\/IJDVL_549_2021\/ref-5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000247540","article-title":"Topical immunotherapy for alopecia areata: Re-evaluation of 139 cases after an additional follow-up period of 19 months","volume":"184","author":"Van DerSteen","year":"1992","journal-title":"Dermatology"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/switching-immune-sensitizer-agents-in-refractory-alopecia-areata-as-a-valuable-therapeutic-strategy-a-retrospective-case-series\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/switching-immune-sensitizer-agents-in-refractory-alopecia-areata-as-a-valuable-therapeutic-strategy-a-retrospective-case-series\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T11:47:00Z","timestamp":1679312820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/switching-immune-sensitizer-agents-in-refractory-alopecia-areata-as-a-valuable-therapeutic-strategy-a-retrospective-case-series\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":5,"alternative-id":["10.25259\/IJDVL_549_2021"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_549_2021","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,23]]},"article-number":"845"}}